Enzo Biochem | 25: Notification of the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Apr 7 16:15 ET

Enzo Biochem | 8-K: Current report

Mar 31 16:22 ET

Enzo Biochem | 8-K: Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results

Mar 18 16:15 ET

Enzo Biochem | 10-Q: Q2 2025 Earnings Report

Mar 17 16:15 ET

Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Director Radoff Bradley Louis

Jan 17 16:49 ET

Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Director PULLY STEVEN J

Jan 17 16:49 ET

Enzo Biochem | 4: Statement of changes in beneficial ownership of securities-Director COUCHMAN JONATHAN

Jan 17 16:45 ET

Enzo Biochem | 8-K: Current report

Jan 16 16:49 ET

Enzo Biochem | 8-K: Current report

Jan 15 16:35 ET

Enzo Biochem | 8-K: Current report

Jan 14 16:18 ET

Enzo Biochem | 10-Q: Q1 2025 Earnings Report

Dec 16, 2024 16:19 ET

Enzo Biochem | 3: Initial statement of beneficial ownership of securities-Director COUCHMAN JONATHAN

Dec 2, 2024 16:17 ET

Enzo Biochem | ARS: Annual Report to Security Holders

Nov 29, 2024 13:04 ET

Enzo Biochem | DEF 14A: Definitive information statements

Nov 27, 2024 16:18 ET

Enzo Biochem | 8-K: Current report

Nov 25, 2024 16:19 ET

Enzo Biochem | 8-K: Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend

Oct 30, 2024 13:25 ET

Enzo Biochem | 10-K: FY2024 Annual Report

Oct 29, 2024 17:09 ET

Enzo Biochem | 8-K: Current report

Sep 24, 2024 17:22 ET

Enzo Biochem | 8-K: Current report

Aug 14, 2024 16:24 ET

Enzo Biochem | 8-K: Current report

Aug 2, 2024 16:38 ET